Development of a Time-Resolved Fluorescence Resonance Energy Transfer Ultrahigh-Throughput Screening Assay for Targeting the NSD3 and MYC Interaction

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Assay and drug development technologies

• Publication date

  2018-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1089/adt.2017.835PMID 29634317PMCID PMC5865254
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay

  2017cited by this paper
• The OncoPPi network of cancer-focused protein–protein interactions to inform biological insights and therapeutic strategies

  2017influential reference
• In vitro and in vivo anti‐inflammatory effects of theaflavin‐3,3′‐digallate on lipopolysaccharide‐induced inflammation

  2017cited by this paper
• MYC Deregulation in Primary Human Cancers

  2017cited by this paper
• NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler.

  2015cited by this paper
• MYC: connecting selective transcriptional control to global RNA production

  2015cited by this paper
• Theaflavin-3, 3′-digallate decreases human ovarian carcinoma OVCAR-3 cell-induced angiogenesis via Akt and Notch-1 pathways, not via MAPK pathways

  2015cited by this paper
• The NSD family of protein methyltransferases in human cancer.

  2015cited by this paper
• Small-molecule inhibitors of the Myc oncoprotein.

  2015cited by this paper
• NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism.

  2014cited by this paper
• An overview of MYC and its interactome.

  2014cited by this paper
• The hallmarks of cancer

  2012cited by this paper
• MYC on the path to cancer.

  2012cited by this paper
• c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells.

  2012cited by this paper
• Chemical Genomics: Time-Resolved Fluorescence Resonance Energy Transfer Technologies in HTS

  2012cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• A Novel High-Throughput Screening Assay for Discovery of Molecules That Increase Cellular Tetrahydrobiopterin

  2011cited by this paper
• Cancers and the NSD family of histone lysine methyltransferases.

  2011cited by this paper
• Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer.

  2008cited by this paper
• Reflecting on 25 years with MYC

  2008cited by this paper
• Theaflavin-3,3'-digallate, a component of black tea: an inducer of oxidative stress and apoptosis.

  2008cited by this paper
• High-throughput screening assays for the identification of chemical probes.

  2007influential reference
• The histone methyltransferase activity of WHISTLE is important for the induction of apoptosis and HDAC1-mediated transcriptional repression.

  2007cited by this paper
• Characterization of a novel WHSC1-associated SET domain protein with H3K4 and H3K27 methyltransferase activity.

  2006cited by this paper
• The theaflavin monomers inhibit the cancer cells growth in vitro.

  2004cited by this paper
• A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications

  2002cited by this paper
• NSD3, a new SET domain-containing gene, maps to 8p12 and is amplified in human breast cancer cell lines.

  2001cited by this paper
• Suppression of extracellular signals and cell proliferation by the black tea polyphenol, theaflavin-3,3'-digallate.

  1999cited by this paper
• Erratum: Suppression of extracellular signals and cell proliferation by the black tea polyphenol, theaflavin-3,3'-digallate (Carcinogenesis (1999) 20 (733-736))

  1999cited by this paper

• NSD3: A Promising Target for Cancer Therapy

  2025cites this paper
• Evaluation of molecular glue-induced neo-Protein-Protein Interaction with a cell lysate-based TR-FRET assay

  2025cites this paper
• Application of Fluorescence- and Bioluminescence-Based Biosensors in Cancer Drug Discovery

  2024cites this paper
• Detection speed optimization of the OI-RD microscope for ultra-high throughput screening.

  2023cites this paper
• A multiplexed time-resolved fluorescence resonance energy transfer ultrahigh-throughput screening assay for targeting SMAD4-SMAD3-DNA complex

  2023cites this paper
• A multiplexed time-resolved fluorescence resonance energy transfer ultrahigh-throughput screening assay for targeting the SMAD4–SMAD3–DNA complex

  2023cites this paper
• TMPRSS2 and SARS-CoV-2 SPIKE interaction assay for uHTS

  2023cites this paper
• Discovery of the first chemical tools to regulate MKK3-mediated MYC activation in cancer.

  2021cites this paper
• A time-resolved fluorescence resonance energy transfer screening assay for discovery of protein-protein interaction modulators

  2021cites this paper
• Explore Protein-Protein Interactions for Cancer Target Discovery Using the OncoPPi Portal

  2020cites this paper
• Assays and technologies for developing proteolysis targeting chimera degraders

  2020cites this paper
• Chemical Screening of Nuclear Receptor Modulators

  2020cites this paper
• Online informatics resources to facilitate cancer target and chemical probe discovery.

  2020cites this paper
• Meeting Proceedings from ICBS 2018- Toward Translational Impact.

  2019cites this paper
• Understanding histone H3 lysine 36 methylation and its deregulation in disease

  2019cites this paper
• Article A multiplexed time-resolved fluorescence resonance energy transfer ultrahigh-throughput screening assay for targeting the SMAD4–SMAD3–DNA complex

  year unknowncites this paper
• Article Identification and characterization of a TGF-β -independent SMAD4–NFATc1–STAT3 regulatory axis

  year unknowncites this paper